Johnson & Johnson completes $3.05 billion acquisition of Halda Therapeutics
The acquisition adds HLD-0915, a once-daily oral therapy for prostate cancer, to Johnson & Johnson’s nearly 20-year legacy of innovation in the disease
The acquisition adds HLD-0915, a once-daily oral therapy for prostate cancer, to Johnson & Johnson’s nearly 20-year legacy of innovation in the disease
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Captured microbes are then neutralized on engineered microbicidal surfaces
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
Renalyx will continue operating as an independent unit within the group
Subscribe To Our Newsletter & Stay Updated